The impact of 5-FU-based bolus chemotherapy on survival in patients with advanced colorectal cancer

Anticancer Research

Volumn 19, Issue 4 C, 1999, Pages 3447-3449

  Van Halteren, H K ^a,c   Roumen, R M H ^a   Coebergh, J W W ^b   Croiset Van Uchelen, F A A M ^a   Keuning, J J ^a   Vreugdenhil, G ^a  

^a ST JOSEPH HOSPITAL   (Netherlands)

^b The Netherlands   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

5 Fluorouracil; Chemotherapy; Colorectal cancer; Leucovorin; Metastasis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; HEMOGLOBIN; LACTATE DEHYDROGENASE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; LIFE EXPECTANCY; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; METASTASIS; PERITONEUM METASTASIS; PRIORITY JOURNAL; REGRESSION ANALYSIS;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BIOLOGICAL RESPONSE MODIFIERS; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0033405650     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Nordic Gastrointestinal Tumor Adjuvant Chemotherapy Group. Expectancy of primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol 10: 904-911, 1992.
2. Scheithauer W, Rosen H, Kornek GV, Sehesta C, Depisch D: Randomized comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 306: 752-755, 1993.
3. Glimelius B, Hoffman K, Graf W, Haglund U, Nyren O, Pahlman L, et al: Cost- effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol 6: 267-274, 1995.
4. Yano T, Fukuyama Y, Yokoyama H, et al: Failure in resection of multiple pulmonary metastases from colorectal cancer. J Am Coll Surg 185: 120-122, 1997.
5. Van Halteren HK, van Geel AN, Hart AA, Zoetmulder FA: Pulmonary resection for metastases of colorectal origin. Chest 107: 1526-1531, 1995.
6. Mc Cormack PM, Burt ME, Bains MS, Martini N, Rusch VW, Ginsberg RJ: Lung resection for colorectal metastases: 10-year results. Arch Surg 127: 1403-1406, 1992.
7. Hugh TJ, Kinsella AR, Poston GJ: Management strategies for colorectal liver metastases. Surg Oncol 6: 19-48, 1997.
8. Tuttle TM, Curley SA, Roh MS: Repeat liver resection as effective treatment of recurrent colorectal liver metastases. Ann Surg Oncol 4: 125-130, 1997.
9. Breimer-Linckens EM, Vreugdenhil G, Keuning JJ, van Halteren HK, Vingerhoets AJJM: Factors determining the appreciation of treatment by advanced colorectal cancer patients. Eur J Cancer 33 (suppl. 8): s60, 1997.
10. Advanced Colorectal cancer Meta-analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10: 896-903, 1992.